2
Clinical Trials associated with Human Fibrinogen(Shandong Taibang Biological Products)评价人纤维蛋白原治疗获得性纤维蛋白原减少症疗效及安全性的阳性药平行对照、随机、双盲、多中心临床研究
[Translation] A positive drug parallel controlled, randomized, double-blind, multicenter clinical study to evaluate the efficacy and safety of human fibrinogen in the treatment of acquired fibrinogenopenia
评价人纤维蛋白原治疗获得性纤维蛋白原减少症的疗效及安全性,为注册提供临床依据
[Translation] To evaluate the efficacy and safety of human fibrinogen in the treatment of acquired fibrinogenopenia and provide clinical basis for registration
人纤维蛋白原(FCH)治疗先天性纤维蛋白原减少或缺乏症患者的疗效和安全性的多中心临床研究
[Translation] A multicenter clinical study on the efficacy and safety of human fibrinogen (FCH) in the treatment of patients with congenital fibrinogen deficiency or deficiency
观察人纤维蛋白原(FCH)治疗先天性纤维蛋白原减少或缺乏症患者的疗效和安全性。
[Translation] To observe the efficacy and safety of human fibrinogen (FCH) in the treatment of patients with congenital fibrinogen deficiency or deficiency.
100 Clinical Results associated with Human Fibrinogen(Shandong Taibang Biological Products)
100 Translational Medicine associated with Human Fibrinogen(Shandong Taibang Biological Products)
100 Patents (Medical) associated with Human Fibrinogen(Shandong Taibang Biological Products)
100 Deals associated with Human Fibrinogen(Shandong Taibang Biological Products)